22-46364139-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001378328.1(CELSR1):​c.8892G>A​(p.Ser2964Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000367 in 1,607,532 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.000060 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

CELSR1
NM_001378328.1 synonymous

Scores

2

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -1.95

Publications

1 publications found
Variant links:
Genes affected
CELSR1 (HGNC:1850): (cadherin EGF LAG seven-pass G-type receptor 1) The protein encoded by this gene is a member of the flamingo subfamily, part of the cadherin superfamily. The flamingo subfamily consists of nonclassic-type cadherins; a subpopulation that does not interact with catenins. The flamingo cadherins are located at the plasma membrane and have nine cadherin domains, seven epidermal growth factor-like repeats and two laminin A G-type repeats in their ectodomain. They also have seven transmembrane domains, a characteristic unique to this subfamily. It is postulated that these proteins are receptors involved in contact-mediated communication, with cadherin domains acting as homophilic binding regions and the EGF-like domains involved in cell adhesion and receptor-ligand interactions. This particular member is a developmentally regulated, neural-specific gene which plays an unspecified role in early embryogenesis. [provided by RefSeq, Jul 2008]
CELSR1 Gene-Disease associations (from GenCC):
  • lymphatic malformation 9
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • neural tube defects, susceptibility to
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hydrops fetalis
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 22-46364139-C-T is Benign according to our data. Variant chr22-46364139-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 3036476.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000601 (9/149828) while in subpopulation SAS AF = 0.000207 (1/4836). AF 95% confidence interval is 0.0000496. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001378328.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CELSR1
NM_001378328.1
MANE Select
c.8892G>Ap.Ser2964Ser
synonymous
Exon 34 of 35NP_001365257.1A0A6I8PRU0
CELSR1
NM_014246.4
c.8892G>Ap.Ser2964Ser
synonymous
Exon 34 of 35NP_055061.1Q9NYQ6-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CELSR1
ENST00000674500.2
MANE Select
c.8892G>Ap.Ser2964Ser
synonymous
Exon 34 of 35ENSP00000501367.2A0A6I8PRU0
CELSR1
ENST00000262738.9
TSL:1
c.8892G>Ap.Ser2964Ser
synonymous
Exon 34 of 35ENSP00000262738.3Q9NYQ6-1
CELSR1
ENST00000473624.2
TSL:1
c.645G>Ap.Ser215Ser
synonymous
Exon 5 of 5ENSP00000501353.1A0A6I8PL36

Frequencies

GnomAD3 genomes
AF:
0.0000601
AC:
9
AN:
149828
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000128
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000805
AC:
20
AN:
248568
AF XY:
0.0000814
show subpopulations
Gnomad AFR exome
AF:
0.000188
Gnomad AMR exome
AF:
0.000232
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000219
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000448
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000343
AC:
50
AN:
1457704
Hom.:
0
Cov.:
31
AF XY:
0.0000317
AC XY:
23
AN XY:
725394
show subpopulations
African (AFR)
AF:
0.000221
AC:
7
AN:
31644
American (AMR)
AF:
0.000135
AC:
6
AN:
44562
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26112
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39680
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51992
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000252
AC:
28
AN:
1111584
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000601
AC:
9
AN:
149828
Hom.:
0
Cov.:
33
AF XY:
0.0000410
AC XY:
3
AN XY:
73224
show subpopulations
African (AFR)
AF:
0.000128
AC:
5
AN:
39166
American (AMR)
AF:
0.00
AC:
0
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000192
AC:
1
AN:
5200
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000565
Hom.:
0
Bravo
AF:
0.0000529
EpiCase
AF:
0.00
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CELSR1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.018
DANN
Benign
0.42
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375507061; hg19: chr22-46760036; COSMIC: COSV53088554; API